Patent details

300242 Product Name: Sorafenib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, in het bijzonder het tosylaat zout

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300242
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1140840
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300242
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/06/342/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
21/07/2006
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
12/10/2006
First Marketing Authorization date:
21/07/2006
Grant date:
05/02/2007
Activation date:
12/01/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
12/10/2006
SPC/SPC Extension Expiration Date:
20/07/2021
Lapsed By Expiration Date:
21/07/2021
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
13/07/2018
 
 

 

Name:
Bayer HealthCare, LLC
Address:
100 Bayer Boulevard, 07981, Whippany, NJ, United States of America (US)

Historical Applicant/holder

From:
12/10/2006
To:
13/07/2018

 

Name:
Bayer Pharmaceuticals Corporation
Address:
400 Morgan Lane, 06516-4175, West Haven, Connecticut, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
12/10/2006
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
29/21
Publication date:
21/07/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
03/20
Publication date:
15/01/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
CO
Journal edition number:
31/18
Publication date:
25/07/2018
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
2007/04
Publication date:
02/04/2007
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
2006/12
Publication date:
01/12/2006
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801267A
Date Registered:
13/07/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Bayer HealthCare, LLC
Address:
100 Bayer Boulevard, 07981, Whippany, NJ, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
29/12/2020
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
05/01/2016 SPC Documents Certificate SPC 1 PDF /2/4/2/0/0/0400300242/docs/300242_3_supplprotectioncertificate20200901120000997.pdf
05/01/2016 Outgoing Correspondence Decision grant 1 PDF /2/4/2/0/0/0400300242/docs/300242_10_outgoingcorrespondence20200901120143778.pdf
02/11/2015 SPC Documents Annex SPC 8 PDF /2/4/2/0/0/0400300242/docs/300242_1_supplprotectioncertificate20200901115436691.pdf
02/11/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/4/2/0/0/0400300242/docs/300242_13_incomingcorrespondencepaper20210308040656240.pdf
05/02/2007 Outgoing Correspondence Outgoing Letter 1 PDF /2/4/2/0/0/0400300242/docs/300242_12_outgoingcorrespondence20070205.pdf
05/02/2007 SPC Documents Certificate SPC 1 PDF /2/4/2/0/0/0400300242/docs/300242_14_supplprotectioncertificate20200910040313373.pdf
30/01/2007 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/4/2/0/0/0400300242/docs/300242_16_incomingcorrespondencepaper20210308040429029.pdf
07/12/2006 SPC Documents Annex SPC 2 PDF /2/4/2/0/0/0400300242/docs/300242_0_supplprotectioncertificate20200901113415623.pdf
07/12/2006 SPC Documents Annex SPC 1 PDF /2/4/2/0/0/0400300242/docs/300242_6_supplprotectioncertificate20200901113130520.pdf
07/12/2006 SPC Documents Annex SPC 2 PDF /2/4/2/0/0/0400300242/docs/300242_7_supplprotectioncertificate20200901112938903.pdf
07/12/2006 SPC Documents Annex SPC 65 PDF /2/4/2/0/0/0400300242/docs/300242_9_supplprotectioncertificate20200901111404415.pdf
07/12/2006 Outgoing Correspondence Outgoing Letter 2 PDF /2/4/2/0/0/0400300242/docs/300242_15_outgoingcorrespondence20061207.pdf
17/10/2006 Outgoing Correspondence Outgoing Letter 1 PDF /2/4/2/0/0/0400300242/docs/300242_5_outgoingcorrespondence20061017.pdf
12/10/2006 SPC Documents Annex SPC 2 PDF /2/4/2/0/0/0400300242/docs/300242_2_supplprotectioncertificate20200901112210437.pdf
12/10/2006 SPC Documents Summary of the characteristics of the product 12 PDF /2/4/2/0/0/0400300242/docs/300242_4_supplprotectioncertificate20200901112210373.pdf
12/10/2006 SPC Documents Annex SPC 12 PDF /2/4/2/0/0/0400300242/docs/300242_8_supplprotectioncertificate20200901112210466.pdf
12/10/2006 Application Form First filed application form 2 PDF /2/4/2/0/0/0400300242/docs/300242_11_applicationform20061012.pdf